A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer-Reference-Cited by-同舟云学术

A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer

Published:2006 Issue:5 Volume:107 Page:1034-1041
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Milton Daniel T.,Azzoli Christopher G.,Heelan Robert T.,Venkatraman Ennapadam,Gomez Jorge E.,Kris Mark G.,Krug Lee M.,Pao William,Rizvi Naiyer A.,Dunne Megan,Miller Vincent A.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference32 articles.

1. Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer

2. Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

3. Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

4. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

5. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost minimization and budget impact analysis of viscosupplementation for the treatment of knee osteoarthrosis in El Salvador and Panama;Revista Colombiana de Reumatología (English Edition);2024-04

2. Major hurdles to the use of tyrosine kinase inhibitors in clinical prevention/interception studies: Do preclinical studies with EGFR inhibitors suggest approaches to overcome some of the limitations;Frontiers in Cell and Developmental Biology;2023-04-24

3. Análisis de minimización de costos e impacto presupuestal de la viscosuplementación para el tratamiento de osteoartrosis de rodilla en El Salvador y Panamá;Revista Colombiana de Reumatología;2022-11

4. Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis;Gut;2022-05-30

5. Leptomeningeal metastasis;Neurological Complications of Systemic Cancer and Antineoplastic Therapy;2022